The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CHEMBL146186     3-[3-(aminocarbonylmethyl)-1- benzyl-2...

Synonyms: SureCN7965980, CTK8E7560, LY-311727, AC1L4F87, LY311727, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of AIDS-122625


High impact information on AIDS-122625

  • Furthermore, the optimized structure (LY311727) displayed 1,500-fold selectivity when assayed against porcine pancreatic s-PLA2 [2].
  • Interestingly, the expression of sPLA2-IIA induced by TNF alpha alone is also attenuated by MK886, by the sPLA2-IIA inhibitor LY311727, by heparinase, which prevents the binding of sPLA2-IIA to heparan sulfate proteoglycans, and by the specific cPLA2-alpha inhibitor pyrrolidine-1 [3].
  • TNF-induced NF-kappaB activation was also strongly reduced in cells stimulated in the presence of the secretory PLA2 (sPLA2) inhibitors 12-epi-scalaradial and LY311727 [4].
  • However, the sPLA(2) activity observed in spinal cord homogenates was suppressed by addition of LY311727, a selective sPLA(2) inhibitor [1].
  • This was supported by the finding that the LPS-induced chemokine production was not affected by the selective sPLA(2) inhibitor LY311727 [5].

Gene context of AIDS-122625

  • Treatment with IFN-gamma and IL-1alpha for 15 min induced a rapid increase of AA release from NHBE cells, which was blocked by the cPLA(2) inhibitor MAFP (p<0.05) but not by the sPLA(2) inhibitor LY311727 or iPLA(2) inhibitor HELSS [6].


  1. Spinal phospholipase A2 in inflammatory hyperalgesia: role of the small, secretory phospholipase A2. Svensson, C.I., Lucas, K.K., Hua, X.Y., Powell, H.C., Dennis, E.A., Yaksh, T.L. Neuroscience (2005) [Pubmed]
  2. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Schevitz, R.W., Bach, N.J., Carlson, D.G., Chirgadze, N.Y., Clawson, D.K., Dillard, R.D., Draheim, S.E., Hartley, L.W., Jones, N.D., Mihelich, E.D. Nat. Struct. Biol. (1995) [Pubmed]
  3. Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation. Beck, S., Lambeau, G., Scholz-Pedretti, K., Gelb, M.H., Janssen, M.J., Edwards, S.H., Wilton, D.C., Pfeilschifter, J., Kaszkin, M. J. Biol. Chem. (2003) [Pubmed]
  4. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. Thommesen, L., Sjursen, W., Gåsvik, K., Hanssen, W., Brekke, O.L., Skattebøl, L., Holmeide, A.K., Espevik, T., Johansen, B., Laegreid, A. J. Immunol. (1998) [Pubmed]
  5. Inhibition of LPS-induced chemokine production in human lung endothelial cells by lipid conjugates anchored to the membrane. Beck, G.C.h., Yard, B.A., Schulte, J., Oberacker, R., van Ackern, K., van Der Woude, F.J., Krimsky, M., Kaszkin, M., Yedgar, S. Br. J. Pharmacol. (2002) [Pubmed]
  6. Involvement of p38 and p42/44 MAP kinases and protein kinase C in the interferon-gamma and interleukin-1alpha-induced phosphorylation of 85-kDa cytosolic phospholipase A(2) in primary human bronchial epithelial cells. Wu, T., Han, C., Shelhamer, J.H. Cytokine (2004) [Pubmed]
WikiGenes - Universities